Recombinant porcine factor VIII use in bleed treatment in non-severe haemophilia A inhibitor patients: Dosing strategies and efficacy

Haemophilia. 2021 Jan;27(1):e147-e150. doi: 10.1111/hae.14111. Epub 2020 Aug 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Factor VIII*
  • Hemophilia A* / complications
  • Hemophilia A* / drug therapy
  • Hemorrhage
  • Humans
  • Recombinant Proteins
  • Swine

Substances

  • Recombinant Proteins
  • Factor VIII